Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-18

Clinical Trial Update: Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

View source ↗

Summary

Ongoing clinical trial evaluating language, speech, and motor function in individuals with Alzheimer's disease and mild cognitive impairment due to Alzheimer's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hanze University of Applied Sciences Groningen | Conditions: Alzheimer's Disease, MCI Due to AD | Status: RECRUITING